Arax Advisory Partners’s Vicarious Surgical RBOT Stock Holding History

Arax Advisory Partners’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-180	Closed	-$992	–	4446
2025 Q3	$992	Hold	180	–	–	﹤0.01%	3259
2025 Q2	$1.35K	Hold	180	–	–	﹤0.01%	2683
2025 Q1	$1.18K	Sell	180 -122	-40%	-$1.44K	﹤0.01%	2253
2024 Q4	$3.98K	Hold	302	–	–	﹤0.01%	1821
2024 Q3	$1.72K	Sell	302 -2,166	-88%	-$14.4K	﹤0.01%	2108
2024 Q2	$14.5K	Sell	2,468 -1,129	-31%	-$10.1K	﹤0.01%	1094
2024 Q1	$32.5K	Buy	3,597 +667	+23%	+$7.96K	﹤0.01%	577
2023 Q4	$32.2K	Buy	2,930 +2,000	+215%	+$22.3K	﹤0.01%	559
2023 Q3	$16.5K	Buy	930 +500	+116%	+$18.2K	﹤0.01%	623
2023 Q2	$23.6K	Buy	+430	New	+$27.4K	﹤0.01%	561

Other funds holding RBOT

VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

MAM

Maytree Asset Management Hong Kong $154M AUM 453.79% 1-Year Est. Return

Arax Advisory Partners's RBOT Position: Q4 2025 in Review

Arax Advisory Partners sold out of Vicarious Surgical (RBOT) in Q4 2025, closing a stake of 180 shares — an estimated $992 sold.

Arax Advisory Partners first reported a position in RBOT in Q2 2023 and held it in 10 quarters. The position peaked at $32.5K in Q1 2024. 36 funds tracked by Wall St. Rank hold RBOT as of Q4 2025.

Arax Advisory Partners reported no remaining Vicarious Surgical position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 180 Vicarious Surgical shares in Q4 2025, an estimated $992.
Arax Advisory Partners first reported a position in Vicarious Surgical in Q2 2023 and held it in 10 quarters.
Arax Advisory Partners's Vicarious Surgical position peaked at $32.5K in Q1 2024.
36 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.